AI Article Synopsis

  • The study tracked undergraduate students over 8 months to gather data on the early stages of primary Epstein-Barr virus (EBV) infection, focusing on those who were EBV-naive and monitored biweekly.
  • A total of 14 out of 85 participants developed primary EBV infections, with deep kissing identified as the only significant risk factor for acquiring the virus.
  • The research highlighted that higher levels of gp350 antibodies were linked to milder cases of infectious mononucleosis, supporting the potential development of a gp350-based vaccine for EBV.

Article Abstract

We performed an intensive prospective study designed to obtain as much data as possible on the incubation and early illness periods of primary Epstein-Barr virus (EBV) infection. Undergraduate students who lacked EBV antibody and oral EBV DNA (EBV-naive) were seen every 2 weeks during their freshman year. Clinical and behavioral data, oral washes and venous blood were obtained. EBV antibodies were quantified by enzyme immunoassay and viral loads by PCR. During a median 8 months of observation, 14/85 subjects experienced primary EBV infections (24 cases/100 person-years). The only significant risk factor for acquisition of EBV infection was deep kissing (P=0.02). Eleven subjects had infectious mononucleosis with a median duration of 21 days. Two subjects were hospitalized. Infections were initially identified in 12 subjects by finding EBV DNA in oral cells before onset of symptoms and in 2 subjects by symptom reporting. EBV DNA and viral capsid antigen (VCA) IgM and gp350 IgG antibodies were present in the blood before onset of illness. To provide a more robust evaluation of primary EBV infection in undergraduate university students, we combined data on risk factors and antibody responses from this and an earlier study that used the exact same clinical and laboratory methods. The observation that the only significant risk factor for acquisition of EBV infection was deep kissing was confirmed. Most importantly, higher amounts of gp350 antibody correlated significantly with a lower severity of infectious mononucleosis (P<0.0001), which strengthens the rationale for a gp350-based prophylactic EBV vaccine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007628PMC
http://dx.doi.org/10.1038/cti.2016.48DOI Listing

Publication Analysis

Top Keywords

ebv infection
16
infectious mononucleosis
12
ebv dna
12
ebv
10
university students
8
infection undergraduate
8
primary ebv
8
risk factor
8
factor acquisition
8
acquisition ebv
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!